What is Medifast's cash & equivalents?

Medifast (MED) reported cash & equivalents of $71.53M in Q1 2026.

How has Medifast's cash & equivalents changed year-over-year?

Medifast's cash & equivalents decreased by 22.0% year-over-year, from $91.72M to $71.53M.

What is the long-term trend for Medifast's cash & equivalents?

Over 5 years (2020 to 2025), Medifast's cash & equivalents has grown at a -11.4% compound annual growth rate (CAGR), from $163.72M to $89.3M.

What does cash & equivalents mean?

Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.

Medifast MED Cash & Equivalents

Cash & Equivalents at other companies

Eli LillyLLY

$5.28B+70.8%

WW International, Inc.WW

$120.87M-48.9%

HerbalifeHLF

$451.2M+37.0%

Omada Health, Inc. Common StockOMDA

$211.77M+257%

Lifevantage CorporationLFVN

$12.48M-44.4%

The Beachbody CompanyBODI

$36.59M+102%

Other financials

Income statement

See full

Revenue$76.0M-34.3%

Gross profit$51.8M-38.6%

Operating income-$3.3M-161%

Net income-$2.1M-175%

EPS (diluted)-$0.19-171%

Balance sheet

See full

Total debt$16.1M+10.2%

Total equity$197.7M-6.3%

Total assets$252.0M-10.0%

Cash flow

See full

Operating cash flow$260.0K-92.4%

CapEx$1.1M-28.0%

Free cash flow-$836.0K-144%

Valuation

See full

Market cap$121.87M-17.4%

Enterprise value$66.44M+12.8%

P/S0.4×0.0×

Profitability

See full

Gross margin70.1%-3.8pp

Operating margin-4.7%-7.0pp

Net margin-5.8%-8.1pp

FCF margin5%-9.3pp

Returns & leverage

See full

Return on equity-9.8%-20.1pp

Debt / equity0.1×0.0×

Current ratio4.8×+1.3×

Where this comes from

Reported directly by Medifast in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.

The official record: Medifast’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Medifast's cash & equivalents.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Medifast's cash & equivalents?: Medifast (MED) reported cash & equivalents of $71.53M in Q1 2026.
How has Medifast's cash & equivalents changed year-over-year?: Medifast's cash & equivalents decreased by 22.0% year-over-year, from $91.72M to $71.53M.
What is the long-term trend for Medifast's cash & equivalents?: Over 5 years (2020 to 2025), Medifast's cash & equivalents has grown at a -11.4% compound annual growth rate (CAGR), from $163.72M to $89.3M.
What does cash & equivalents mean?: Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.